INIS
assessments
16%
biological markers
16%
breasts
100%
cancer
100%
correlations
16%
diseases
16%
dna
100%
guidelines
33%
hormones
100%
levels
16%
methylation
100%
panels
33%
patients
33%
populations
16%
prediction
16%
receptors
100%
reviews
100%
risks
33%
values
16%
variations
16%
Keyphrases
Biomarker Studies
16%
Brca
16%
Breast Cancer
100%
Cancer Types
16%
CDH1
16%
Clinical Parameters
16%
Clinical Practice
16%
Disease Outcome
16%
DNA Methylation Markers
100%
Embase
16%
GSTP1
16%
High-risk of Recurrence
16%
Hormone Receptor
100%
Hormone Receptor-positive Breast Cancer
50%
Hypermethylation
16%
Marker Panel
33%
PCDH10
16%
PITX2
16%
Prognostic Biomarker
16%
Prognostic Value
16%
PubMed
16%
RASSF1A
33%
Reporting Guidelines
33%
Reporting Quality
50%
Retinoic Acid Receptor β (RARβ)
16%
Risk Prediction
16%
Single Marker
16%
Standardized Reporting
16%
Medicine and Dentistry
Biomarker Study
16%
Breast Cancer
100%
Cancer Types
16%
Disease
16%
DNA Methylation
100%
Hormone Receptor
100%
Recurrent Disease
16%
Systematic Review
100%
Biochemistry, Genetics and Molecular Biology
Biomarker Study
16%
DNA Methylation
100%
GSTP1
16%
Hormone Receptor
100%
Medline
16%
PCDH10
16%
PITX2
16%
RASSF1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biomarker Study
20%
Breast Cancer
100%
Disease
20%
Hormone Receptor
100%
Malignant Neoplasm
20%
Recurrent Disease
20%